Vektor Medical, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vektor Medical, Inc. - overview
Established
2017
Location
San Diego, CA, US
Primary Industry
Software
About
Based in California, US, and co-founded by Mike Monko (Executive Chairman) David Krummen, Gordon Ho, and Andrew McCulloch, in 2017, Vektor Medical, Inc. operates as a provider of artificial intelligence (AI) technology for arrhythmia treatment. In February 2024, the firm raised USD 16 million in series A funding co-led by Solas BioVentures and TVM Capital Life Science. The firm as of February 2024, is led by its CEO, Rob Krummen.
The company’s flagship product, vMap addresses the global health crisis of arrhythmia by unlocking valuable insights contained in standard electrocardiograms (ECGs). vMap is an advanced algorithm and AI-based arrhythmia analysis tool designed to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. vMap, rapidly and accurately locate source locations for both focal and fibrillation-type arrhythmias. Vektor’s non-invasive, four-chamber mapping tool provides physicians with intuitive and accurate insights, enabling them to streamline both mapping and ablation procedures.
The company plans to utilize the February 2024 funding to accelerate the development of its management and operation.
Current Investors
TVM Capital Life Science, Solas BioVentures
Primary Industry
Software
Sub Industries
Cardiology, Medical Devices & Equipment, Medical Software
Website
www.vektormedical.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.